Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography

NCT04245241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2020-01-28

No results posted yet for this study

Summary

This study aimed to determine the effects of HFNC therapy on lung recruitment and lung strain change assessed by electrical impedance tomography (EIT)

Conditions

  • High-flow Nasal Cannula
  • Electrical Impedance Tomography

Interventions

OTHER

High-flow nasal cannula (HFNC)

24 patients who receiving HFNC within 24 hours after extubation were prospectively enrolled in this study. EIT was used to monitor regional lung ventilation distributions at baseline (conventional oxygen therapy) and three flow rate levels of HFNC therapy (20, 40 and 60 L/min).

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2019-07-01
Completion
2019-11-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245241 on ClinicalTrials.gov